Rohto-Mentholatum (Vietnam) Co., Ltd.

FDA Regulatory Profile

Rohto-Mentholatum (Vietnam) Co., Ltd. appears in FDA public data with 8 recalls, 0 510(k) clearances, 5 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0722-2026, Class II) was initiated on July 14, 2026.

Summary

Total Recalls
8
510(k) Clearances
0
Inspections
5
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0722-2026Class IIRohto Cooling Eye Drops Cool Relief (naphazoline hydrochloride 0.012%, polysorbate 80 0.2%), SterileJuly 14, 2026
D-0719-2026Class IIRohto Cooling Eye Drops Digi Eye (hypromellose 0.35%, tetrahydrozoline HCl 0.05%), Sterile, 0.4 FL OJuly 14, 2026
D-0717-2026Class IIRohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 80 0.2%), SterileJuly 14, 2026
D-0718-2026Class IIRohto Cooling Eye Drops Optic Glow (naphazoline hydrochloride 0.03%, povidone 0.5%, propylene glycolJuly 14, 2026
D-0715-2026Class IIRohto Cooling Eye Drops ALL-IN-ONE (hypromellose 0.2%, tetrahydrozoline HCL 0.05%, zinc sulfate 0.25July 14, 2026
D-0721-2026Class IIRohto Cooling Eye Drops Dry Aid (povidone 0.68%, propylene glycol 0.3%), Sterile, TWIN PACK 0.34 FL July 14, 2026
D-0720-2026Class IIRohto Cooling Eye Drops Dry Aid (povidone 0.68%, propylene glycol 0.3%), Sterile, 0.34 FL OZ (10 mL)July 14, 2026
D-0716-2026Class IIRohto Cooling Eye Drops Max Strength (naphazoline hydrochloride 0.03%, polysorbate 90, 0.2%), SterilJuly 14, 2026